Literature DB >> 21137724

Silver nanoparticles crossing through and distribution in the blood-brain barrier in vitro.

Jinglong Tang1, Ling Xiong, Guofeng Zhou, Shuo Wang, Jianyu Wang, Li Liu, Jiage Li, Fuqiang Yuan, Songfang Lu, Ziyi Wan, Laisheng Chou, Tingfei Xi.   

Abstract

Silver nanoparticles (SNPs) translocate to the brain through the blood stream after they are implanted in vivo. The aim of this study was to investigate the distribution of SNPs that crossed through the blood-brain barrier (BBB). An in vitro BBB model established by co-cultures of rat brain microvessel vascular endothelial cells (BMVECs) with astrocytes (ACs) was cultured with cell culture medium containing 100 microg/mL of either SNPs or silver microparticles (SMPs). After 4 hours of culture, the ultrastructure and its silver content of BBB was evaluated with transmission electronic microscopy (TEM) and inductively-coupled plasma mass spectrometry (ICP-MS) respectively. Results demonstrated that SNPs crossed the BBB and accumulated inside BMVECs, while the SMPs did not. The data indicated a special distribution of SNPs in the BBB and suggested that SNPs pass the BBB mainly by transcytosis of capillary endothelial cells. Further study would be necessary to evaluate the actual biological effects of SNPs on the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21137724     DOI: 10.1166/jnn.2010.2625

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  34 in total

1.  Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles.

Authors:  Eva M Luther; Maike M Schmidt; Joerg Diendorf; Matthias Epple; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-04-05       Impact factor: 3.996

2.  Silver nanoparticles engineered by thermal co-reduction approach induces liver damage in Wistar rats: acute and sub-chronic toxicity analysis.

Authors:  Nandita Dasgupta; Shivendu Ranjan; Chidambaram Ramalingam; Mansi Gandhi
Journal:  3 Biotech       Date:  2019-03-06       Impact factor: 2.406

3.  Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases.

Authors:  Shima Masoudi Asil; Jyoti Ahlawat; Gileydis Guillama Barroso; Mahesh Narayan
Journal:  Biomater Sci       Date:  2020-07-08       Impact factor: 6.843

4.  Contrasting effects of nanoparticle-protein attraction on amyloid aggregation.

Authors:  Slaven Radic; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  RSC Adv       Date:  2015-12-01       Impact factor: 3.361

5.  NanoEHS beyond Toxicity - Focusing on Biocorona.

Authors:  Sijie Lin; Monika Mortimer; Ran Chen; Aleksandr Kakinen; Jim E Riviere; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Environ Sci Nano       Date:  2017-06-01

Review 6.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

7.  Concentration-dependent toxicogenomic changes of silver nanoparticles in hepatocyte-like cells derived from human induced pluripotent stem cells.

Authors:  Xiugong Gao; Rong Li; Robert L Sprando; Jeffrey J Yourick
Journal:  Cell Biol Toxicol       Date:  2020-05-24       Impact factor: 6.691

8.  Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel.

Authors:  Liming Xu; Xuefei Li; Taro Takemura; Nobutaka Hanagata; Gang Wu; Laisheng Lee Chou
Journal:  J Nanobiotechnology       Date:  2012-05-01       Impact factor: 10.435

9.  Toxicology and clinical potential of nanoparticles.

Authors:  Lara Yildirimer; Nguyen T K Thanh; Marilena Loizidou; Alexander M Seifalian
Journal:  Nano Today       Date:  2011-12       Impact factor: 20.722

Review 10.  Remodelling and Treatment of the Blood-Brain Barrier in Glioma.

Authors:  Yihao Wang; Fangcheng Zhang; Nanxiang Xiong; Hao Xu; Songshan Chai; Haofei Wang; Jiajing Wang; Hongyang Zhao; Xiaobing Jiang; Peng Fu; Wei Xiang
Journal:  Cancer Manag Res       Date:  2021-05-27       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.